This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
Antofagasta | Citigroup ups TP to 1000p from 990p, sell |
AstraZeneca | Exane BNP Paribas ups TP by 3 percent to 3,100p, neutral |
Aviva | Bernstein cuts TP to 360p from 410p, market-perform |
AZ Electronic Materials | Liberum initiates with Buy rating; TP of 440p |
British Land | Deutsche Bank cuts TP to 720P from 740P |
easyJet | UBS ups TP to 1,175p from 1,000p, Buy |
Faroe Petroleum | Liberum initiates with Buy rating; TP of 198p |
Faroe Petroleum | HSBC initiates with overweight rating |
Ferrexpo | Deutsche Bank cuts TP to 370P from 390P |
G4S | Jefferies ups TP to 340p from 275p, Buy |
G4S | Exane BNP Paribas ups TP by 12 percent to 330p, outperform |
Hikma | UBS ups TP to 805p from 755p, sell |
Hochschild Mining | SocGen cuts TP to 300p from 330p, sell |
IG Group | Citigroup ups TP to 625p from 500p, Buy |
Intu Properties | UBS cuts TP to 345p from 365p, neutral |
MAN Group | RBC ups TP to 100p from 95p, sector perform |
MAN Group | Citigroup names as a Least Preferred stock |
Meggitt | Citigroup downgrades to neutral from Buy; ups TP to 500p from 450p |
Perform Group | UBS ups TP to 490p from 425p, Buy |
RPS Group | Investec ups TP to 310p from 275p; raing Buy |
Smiths News | Liberum ups TP to 188p from 170p, Buy |
ST Ives | N+1 Singer ups TP to 172p from 129p, Buy |
Thomas Cook | UBS ups TP to 125p from 100p, Buy |
Thomas Cook | Morgan Stanley ups TP to 150P from 100P |
Thomas Cook | HSBC ups TP to 130P from 100P |
Thomas Cook | Morgan Stanley ups TP to 150P from 100P |
Vesuvius | UBS ups TP to 375p from 315p, neutral |
Source: Reuters News, AlphaTerminal, Dow Jones Newswires |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research